Syneos Health Inc

SYNH's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

SYNH Growth rates comparisons

Looking into Syneos Health Inc growth rates, revenue grew by 0.39 % in the second quarter of 2023 from the same quarter a year ago. Ranking at No. 2317

Medical Laboratories industry recorded growth of revenues by 3.78 %

Syneos Health Inc 's net profit decreased by -98.98 % in second quarter of 2023 year on year, to $1 millions.

• More on SYNH's Growth

SYNH's Valuation comparisons

Syneos Health Inc
current PE on trailing twelve month basis is above Medical Laboratories industry average.

Syneos Health Inc realized cash reduction of $ -0.23 per share in trailing twelve-month period.

Company

62.33

PE TTM

Industry

-0

PE TTM

Company's Price to Sales ratio is at 0.83.
Medical Laboratories industry's Price to Sales ratio is at 2.84.

• More on SYNH's Valuation

Total Debt (Millions $)	2,650
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	216,759
Net Income/Employee (TTM) $	2,849
Receivable Turnover (TTM)	-
Tangible Book Value (Per Share $)	-19.42

SYNH's Valuation comparisons

Syneos Health Inc
current PE on trailing twelve month basis is above Medical Laboratories industry average.

Syneos Health Inc realized cash outflow of $ -0.23per share in trailing twelve-month period.

Company

62.33

PE TTM

Industry

-0

PE TTM

Company's Price to Sales ratio is at 0.83.
Medical Laboratories industry's Price to Sales ratio is at 2.84.

Syneos Health Inc Price to Book Ratio is at 1.28 lower than Industry Avg. of 444.9. and higher than S&P 500 Avg. of 0.02

• More on SYNH's Valuation

• Market Capitalization (Millions $)	4,485
• Shares Outstanding (Millions)	104
• Employees	25,000
• Revenues (TTM) (Millions $)	5,419
• Net Income (TTM) (Millions $)	71
• Cash Flow (TTM) (Millions $)	-24
• Capital Exp. (TTM) (Millions $)	-91
• Total Debt (Millions $)	2,650
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	216,759
• Net Income/Employee(TTM) $	2,849
• Receivable Turnover Ratio (TTM)	-
• Tangible Book Value (Per Share $)	-19.42

• Market Capitalization (Millions $)	4,485
• Shares Outstanding (Millions)	104
• Employees	25,000
• Revenues (TTM) (Millions $)	5,419
• Net Income (TTM) (Millions $)	71
• Cash Flow (TTM) (Millions $)	-24
• Capital Exp. (TTM) (Millions $)	-91

SYNH's Profitability Comparisons
Syneos Health Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in second quarter of 2023 to 3.09 %. Syneos Health Inc net profit margin of 0.06 % is currently ranking no. 12 in Medical Laboratories industry, ranking no. 196 in Healthcare sector and number 2506 in S&P 500.

	*Ratio*
• Capital Ratio (MRQ)	1.2
• Total Debt to Equity (MRQ)	0.76
• Tangible Leverage Ratio (MRQ)	-
• Asset Turnover Ratio (TTM)	0.67
• Inventory Turnover Ratio (TTM)	-

SYNH's Profitability Comparisons

Syneos Health Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in second quarter of 2023 to 3.09 %.

Syneos Health Inc net profit margin of 0.06 % is currently ranking no. 12 in Medical Laboratories industry, ranking no. 196 in Healthcare sector and number 2506 in S&P 500.

• More on SYNH's Key Ratios

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.